Low Expression of ZHX3 Is Associated with Progression and Poor Prognosis in Colorectal Cancer

Scientists analyzed the protein levels of ZHX3 by immunohistochemistry and evaluated its relationship with the clinicopathological features and prognosis in 286 colorectal cancer patients.